Brown Brothers Harriman & Co’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-96
Closed -$4.43K 1861
2025
Q3
$4.43K Buy
+96
New +$5.12K ﹤0.01% 1449
2025
Q2
Sell
-265
Closed -$14.7K 1563
2025
Q1
$14.7K Hold
265
﹤0.01% 1008
2024
Q4
$11.5K Sell
265
-145
-35% -$6.45K ﹤0.01% 1107
2024
Q3
$21K Hold
410
﹤0.01% 939
2024
Q2
$25.9K Hold
410
﹤0.01% 856
2024
Q1
$27.1K Buy
410
+145
+55% +$11.8K ﹤0.01% 854
2023
Q4
$26K Hold
265
﹤0.01% 815
2023
Q3
$21.2K Hold
265
﹤0.01% 829
2023
Q2
$21.4K Sell
265
-30
-10% -$2.81K ﹤0.01% 847
2023
Q1
$35.9K Buy
295
+30
+11% +$4.07K ﹤0.01% 791
2022
Q4
$35.3K Hold
265
﹤0.01% 778
2022
Q3
$30K Hold
265
﹤0.01% 864
2022
Q2
$36K Hold
265
﹤0.01% 756
2022
Q1
$44K Sell
265
-260
-50% -$49.4K ﹤0.01% 798
2021
Q4
$94K Hold
525
﹤0.01% 600
2021
Q3
$93K Hold
525
﹤0.01% 574
2021
Q2
$84K Hold
525
﹤0.01% 583
2021
Q1
$79K Hold
525
﹤0.01% 561
2020
Q4
$52K Buy
+525
New +$52.5K ﹤0.01% 657

Other funds holding CNXC

Brown Brothers Harriman & Co's CNXC Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 96 shares — an estimated $4.43K sold.

Brown Brothers Harriman & Co first reported a position in CNXC in Q4 2020 and held it in 19 quarters. The position peaked at $94K in Q4 2021. 336 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Brown Brothers Harriman & Co reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 96 Concentrix shares in Q4 2025, an estimated $4.43K.
  • Brown Brothers Harriman & Co first reported a position in Concentrix in Q4 2020 and held it in 19 quarters.
  • Brown Brothers Harriman & Co's Concentrix position peaked at $94K in Q4 2021.
  • 336 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.